$1.60
+0.07 (+4.58%)
Open$1.57
Previous Close$1.53
Day High$1.69
Day Low$1.55
52W High$4.75
52W Low$1.35
Volume—
Avg Volume347.6K
Market Cap53.99M
P/E Ratio2.00
EPS$0.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+944.4% upside
Current
$1.60
$1.60
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 196.53M | 186.78M | 22.38M |
| Net Income | 27.65M | 23.65M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 53.39M | 48.20M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |